GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Accounts Receivable

Bide Pharmatech Co (SHSE:688073) Accounts Receivable : ¥243 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Bide Pharmatech Co's accounts receivables for the quarter that ended in Mar. 2024 was ¥243 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Bide Pharmatech Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 84.54.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Bide Pharmatech Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was ¥16.10.


Bide Pharmatech Co Accounts Receivable Historical Data

The historical data trend for Bide Pharmatech Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bide Pharmatech Co Accounts Receivable Chart

Bide Pharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial 52.37 84.94 124.68 177.03 235.01

Bide Pharmatech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 219.43 225.18 257.53 235.01 243.35

Bide Pharmatech Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Bide Pharmatech Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Bide Pharmatech Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=243.35/262.67*91
=84.54

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Bide Pharmatech Co's accounts receivable are only considered to be worth 75% of book value:

Bide Pharmatech Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1281.97+0.75 * 243.35+0.5 * 670.411-336.679
-0-0)/90.8829
=16.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Bide Pharmatech Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Bide Pharmatech Co (SHSE:688073) Business Description

Traded in Other Exchanges
N/A
Address
No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433
Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.
Executives
Dai Lan Director

Bide Pharmatech Co (SHSE:688073) Headlines

No Headlines